Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Why Is Soleno Therapeutics (SLNO) Stock Up 130% Today?

With Soleno Therapeutics receiving a financial commitment, SLNO stock skyrocketed. Still, prospective investors should be careful.

BLUE Stock Alert: What to Know as the FDA Lifts Hold on Bluebird Bio Treatment

In a counterintuitive move, traders are selling BLUE stock even as Bluebird Bio claims to be on track with its sickle cell disease treatment.

Why Is Viking Therapeutics (VKTX) Stock Up 67% Today?

Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company.

Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today?

Madrigal Pharmaceuticals (MDGL) stock is rocketing higher on Monday after sharing positive results from its NASH treatment.

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond

Some of the hottest biotech stocks are safe and recession-proof. After all, we can’t stop people from aging – at least, not yet. We can’t…

The 7 Best Retirement Stocks to Buy Now

Current bear market conditions present the perfect opportunity to invest in retirement stocks while they're trading at bargain valuations.

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond

As their respective catalysts (namely new treatments/products) continue to play out, each one of these seven hottest healthcare stocks has a strong chance of making another significant move higher in 2023, and in the years ahead.

OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial

OCGN stock fell into the red despite Ocugen's success in advancing a regenerative cell therapy product evaluation.

Why Is Exact Sciences (EXAS) Stock Up 23% Today?

Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.

3 Penny Stocks With the Potential to 10X in 2023

If you're looking for penny stocks to buy in 2023, these three should pique your interest as they can surge even during a recession.

7 Top-Rated Large-Cap Stocks to Buy and Hold

Large-cap stocks are always great to have in a portfolio. These companies are the biggest – and some of the best-known – stocks in the stock market. That makes finding the best large-cap stocks a worthy exercise.

Why Is Third Harmonic Bio (THRD) Stock Down 75% Today?

THRD stock investors are clearly disappointed after Third Harmonic Bio discontinued its clinical study over safety concerns.

BCRX Stock Sinks as BioCryst Discontinues Drug Development

BioCryst Pharmaceuticals (BCRX) stock is falling on Thursday after revealing it's no longer developing BCX9930 for competitive reasons.

The 7 Hottest Penny Stocks to Own for 2023 and Beyond

Company-specific catalysts could help these seven hottest penny stocks deliver outsized returns in 2023, and in the years ahead.

Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?

KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase.

Why Is Vallon Pharmaceuticals (VLON) Stock Up 95% Today?

Vallon Pharmaceuticals (VLON) stock is rocketing higher on Wednesday as investors react to news of a merger agreement with GRI Bio.

Why Is OpGen (OPGN) Stock Up 148% Today?

OpGen (OPGN) stock is rocketing higher on Tuesday after posting results from its Unyvero urinary tract infections (UTI) clinical trial.

7 ‘Next Big Things’ for Investors to Buy for 2023

The next big thing for investors in 2023 is buying companies with revenue expansion amid what could be a painful economic slowdown.

Why Is Harpoon Therapeutics (HARP) Stock Up 100%+ Today?

Harpoon Therapeutics (HARP) stock is taking off on Monday following the release of updated results from its myeloma drug candidate.